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ABSTRACT
The Mouse Phenome Project was launched a
decade ago to complement mouse genome
sequencing efforts by promoting new phenotyping
initiatives under standardized conditions and col-
lecting the data in a central public database, the
Mouse Phenome Database (MPD; http://phenome
.jax.org). MPD houses a wealth of strain character-
istics data to facilitate the use of the laboratory
mouse in translational research for human health
and disease, helping alleviate problems involving
experimentation in humans that cannot be done
practically or ethically. Data sets are voluntarily
contributed by researchers from a variety of institu-
tions and settings, or in some cases, retrieved by
MPD staff from public sources. MPD maintains a
growing collection of standardized reference data
that assists investigators in selecting mouse
strains for research applications; houses treat-
ment/control data for drug studies and other
interventions; offers a standardized platform for dis-
covering genotype–phenotype relationships; and
provides tools for hypothesis testing. MPD improve-
ments and updates since our last NAR report are
presented, including the addition of new tools and
features to facilitate navigation and data mining as
well as the acquisition of new data (phenotypic,
genotypic and gene expression).
INTRODUCTION
Phenomics, the comprehensive study of phenotypes, com-
plements advances in knowledge from genomics, pharma-
cogenomics and other -omics approaches. Most human
diseases are complex, polygenic and subject to modiﬁca-
tions by environmental, genetic and epigenetic factors. A
phenomics approach requires collecting comprehensive
high-dimensional phenotypic data, integrating it with
other types of diverse biological data, and evaluating it
with computational tools and bioinformatic approaches.
MPD is the only database of its kind—amassing,
annotating, integrating and maintaining quantitative
phenotypic data for the laboratory mouse, and providing
online tools to access and analyze those data. MPD is an
established community resource and research tool
enabling investigators to access thousands of data points
from hundreds of strains, saving time and money by
precluding the need to (re)characterize strains. MPD
provides many tools to facilitate mouse research.
For example, MPD enables users to:
. Compare strains to identify mouse models of human
disease.
. Select optimal genetic backgrounds for new or existing
mutations.
. Take advantage of the MPD Protocol Library contain-
ing detailed, illustrated procedures that have been
validated by experts in their ﬁelds (and further, to
view data generated from these protocols to conﬁrm
experimental results).
. Discover phenotype–genotype relationships and
. Validate and reﬁne results from traditional mapping
studies.
More powerful mapping tools are increasingly essential
and indispensable in the analysis of complex traits and
systems genomics to dramatically reduce the broad,
unwieldy intervals of previously identiﬁed quantitative
trait loci (QTL) containing hundreds (if not thousands)
of genes, down to the gene level. For several years now,
the community has had access to high-density SNP data
for 16 inbred strains at over 8 million genome-wide loca-
tions through the NIEHS-Perlegen resequencing effort (1)
and for 94 strains at 132K locations provided by the
Mouse HapMap Project (2). These data were used to
develop a novel high-density genotyping array, the
Mouse Diversity Genotyping Array (3) (see also http://
cgd/tools/diversityarray.shtml). These SNP data sets are
available in MPD: Perlegen2 (4), Broad2 (5) and CGD2
(6), respectively. MPD has Mouse Diversity Array data
for 123 inbred strains at 550K locations. In addition, the
Wellcome Trust Sanger Institute recently released
whole-genome sequence data for 17 inbred mouse strains
and is generating transcriptome data (RNA-Seq) for these
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data, transcriptome and dense genotypic data enable the
identiﬁcation of regions of the genome that may be causal
to a phenotype of interest through correlative analyses.
Sanger SNPs, indels and structural variants will be
added to MPD and made available in the coming months.
MPD history, standards, schema and other topics have
been presented elsewhere (9–11). Here, we review a few
salient points regarding MPD contents. The recommended
basic study design is a strain survey format, e.g. 10 females
and 10 males of a large number of genetically stable, re-
producible strains (such as inbred strains). Acquired data
sets are annotated and formatted to meet a set of deﬁned
MPD standards. Each data set is accompanied by a
detailed protocol; health status and environmental param-
eters of the test animals; and any other information essen-
tial to understanding and evaluating the data. Data and
documentation are then bundled together into an MPD
‘project’, which is given a descriptive title and annotated
with submitter information, references and funding
acknowledgements.
MPD phenotypic data sets are typically quantitative,
although we do house categorical data such as MHC
haplotypes and a growing collection of annotated
images. Data from microarray gene expression studies
are considered a special class of phenotype data and
handled accordingly. Summary statistics are computed
as part of the MPD accessioning process, where the unit
of analysis is an MPD ‘measurement’ with strain (by sex)
being the analysis group. Each measurement in a data set
is classiﬁed and integrated in the MPD phenotype
category structure. Male and female data are not
combined. Data from different MPD measurements are
not averaged together although these data may be dis-
played in the same plot for comparison (composite/con-
sensus view). As part of the accessioning process,
regression analysis is performed on all measurements
(pair-wise) to identify compelling correlations, which
may indicate common genetic determinants or
overlapping biological pathways. Results are stored to
optimize and support queries based on correlations.
Strain genotypes are collected and stored in MPD so
that phenotypic and genotypic data can be linked or
visually juxtaposed, facilitating the ability to determine
how allele-speciﬁc variations translate to variation in
mouse phenotype.
Our last NAR update was published in 2009 (11). Here,
we summarize new data and data types, and describe
major improvements in MPD functionality. This update
refers to Supplementary Data.
CONTENTS
‘MPD current contents’ are summarized in Table 1, and a
snapshot of ‘What’s New’ is shown in Table 2. Users can
search the database by our keyword search, or browse by
strain, phenotype category, data submitter, interventions,
study design and other convenient groupings
(Supplementary Data, Navigation and Finding Data:
S1–S8). Brieﬂy, over 750 strains of mice are represented
in MPD with phenotypic and/or genotypic data available.
Strain names are kept updated with current nomenclature,
and linkouts to other databases are provided. Table 1
provides an inventory of strains, strain panels and strain
sources (also Search or Browse Strains: S1, S2, S3).
Investigators associated with MPD as data contributors
or as formal collaborators represent approximately 150
institutions from 14 countries supported by over 80
funding agencies and research foundations worldwide
(Investigators: S4; Large-Scale Initiatives: S5).
Phenotype data
MPD contains approximately 3000 phenotypic strain
survey measurements, collectively representing approxi-
mately 600 of the 750+ strains in MPD (Find
Measurements: S6, S7, S8). Most measurements (70%)
include data for both sexes. On an average, 20 strains
are tested per measurement, but as many as 72 strains
have been tested in a single project (CGDpheno1,
pending). Currently available phenotypic measurements
are classiﬁed as baseline (64%), aging-related data
(14%) or controlled studies of intervention effects
Table 1. MPD current contents
Phenotype measurements (including pending) [S7]
collectively 600 strains
3000
SNPs [S11]
Total calls (excluding imputed) 350 million
Genomic locations 8+ million
Number of strains with data 450+
Gene expression strain surveys [S12]8
Number of probesets 280K
Strains [S2, S3] 761
Strain types
Inbred 208
Recombinant inbred strains 330
F1 hybrids 87
Wild-derived inbred 70
Chromosome substitution strains 38
Other 28
Recombinant inbred panels 9
AKXD
AXB
BXA
BXD
BXH
CXB
ILSXISS
LGXSM
SWXJ
Chromosome substitution panels 2
C57BL/6J-Chr#
A/J/NaJ 23
C57BL/6J-Chr#
PWD/Ph/ForeJ 19
Animal vendors and repositories 10
Animal Resources Centre (AUS)
B&K Universal (UK)
Charles River
Harlan Laboratories
The Jackson Laboratory
Nihon Clea, Tokyo (Japan)
Pasteur Institute (France)
RIKEN BioResource Center (Japan)
National Institute of Genetics—Shigen (Japan)
Taconic
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(Interventions: S8). MPD has acquired and formatted
hundreds of experimental procedures, housing a library
of protocols where detailed procedures and assays are
maintained so that the research community may beneﬁt
from their use (Protocols: S9, S10).
Genotype data
The current MPD SNP database contains 350 million
SNP calls (count excludes imputed SNPs) obtained from
approximately 30 publicly available or contributed SNP
sources, including Broad, Celera, Center for Genome
Dynamics, Merck, Perlegen (NIEHS), Wellcome Trust,
Novartis (GNF) and The Jackson Laboratory (MPD
SNP Database: S11). MPD makes SNPs available in
sets for RI panels (8 total), C57BL/6 substrains (13
variants) and 129 substrains (7 variants). In total,
MPD has SNP data for >450 veriﬁed strains (Find
Strains with SNPs: S2, S3). MPD combines SNP data
with gene annotations from external resources such as
Mouse Genome Informatics (MGI) (12), NCBI dbSNP
(13) and Ensembl (14).
Gene expression data
In addition to new phenotypic and genotypic data, MPD
has recently begun accessioning gene expression strain
survey data. Currently, there are eight gene expression
projects, representing 280K probesets. Four of these
projects are part of a treatment/control paradigm, and
phenotype data are available in parallel. These interven-
tion studies are from two laboratories studying the effects
of a high-fat diet [Shockley1 (15,16)] and an environmen-
tal insult (trichloroethylene exposure) [Rusyn2 (17,18)].
Thus far, data are from either whole brain or liver;
efforts are underway to obtain data from other tissues
and cell types. Most data sets are inbred strain
surveys (10–30 strains), and another is for the ILSXISS
recombinant inbred strain panel (61 strains)
[GX-Tabakoff2 (19)]. Functionality of the new gene
expression interface is showcased below in detail (see
also Gene Expression: S12).
Since our last reporting, we have accessioned over 70
new phenotype or gene expression projects from over 100
investigators representing >40 institutions. See Table 2 for
‘What’s New’ in MPD categories and intervention
groups. Several of these new projects are important drug
studies, including acetaminophen toxicity [Threadgill1,
Threadgill2 (20–23)], haloperidol effects on behavior
[Crowley1 (24,25)] and effects of b-adrenergic drugs on
heart function [Maurer1 (26,27)] (Projects: S6;
Interventions: S8). Most have associated publications,
providing assurance that the study has been peer-reviewed
and the data validated by experts.
FUNCTIONALITY
MPD provides many options to view, analyze and
download data (MPD Toolbox Demo: S13). Since our
last NAR update, we have made signiﬁcant improvements
Table 2. Summary of What’s New since our last NAR update
MPD categories with new data Treatment and intervention
studies [S8] (with new data)
Appearance Dietary interventions
Coat color Capsaicin
Behavior Diet restriction
Anxiety High-fat diet
Exploratory High-fat diet+ethanol
Learning and memory Sucrose
Locomotor activity Drugs and alcohol
Motor coordination and activity Acetaminophen
Social Ethanol
Stress reactivity Fluoxetine
Wildness Haloperidol
Blood Isoniazid
Clinical chemistry Lithium
Hematology b-adrenergic drugs
Lipids Environmental insult
Body composition Trichloroethylene
BMI Infectious diseases
Fat pads Candida
Body metrics Inﬂuenza A (H1N1)
Size, weight, growth curve Malaria
Bone Lifestyle and healthspan
Mineral density and content Aging
Metrics Exercise
Brain
Drug concentration
Gene expression
Cardiovascular
Echocardiography
Blood pressure, heart rate
Cell and tissue damage
Apoptosis
Chromosome instability
Ear
Balance
Hearing
Endocrine
Adrenal morphology
Hormones
Immune system
Cell counts
Immunoglobulins
Response to infection
Kidney
Urinalysis
Vesico-ureteral reﬂux
Liver
Pathology
Homeostasis
Gene expression
Longevity
Lifespan
Metabolism
Body temperature
Energy
Food and water intake
Nervous system
Autonomic function
Neuron projection morphology
Neurogenesis
Neuromuscular function
Sensorimotor function
Neurosensory
Nociception
Sensory gating
Organ metrics
Eye
Kidney
Liver
Spleen
Reproduction
Fecundity
Female
Male
Sex distribution
Respiratory
Airway resistance
Breathing pattern
Lung compliance
Lung volume
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Toolbox. Here, we present a comprehensive example to
demonstrate the power and utility of MPD and to high-
light some of our new tools and features. We start with
MPD phenotype data (IGF-1 levels at 6months of age)
and use new MPD tools to conﬁrm and further narrow
published mapping results (Yuan1) (28,29). This example
spans Figures 1–3 and illustrates the following new or
updated features:
. Improvement of various tools with new layouts, more
options and links to other tools and information
(Figure 1).
. Development of interfaces to facilitate association
mapping using the UCLA EMMA-Correction Server
(see below and Figure 2).
. Implementation of a user interface for working with
gene expression data and providing tools for ﬁnding
signiﬁcant correlations to phenotype data using an in-
novative variance-based, data-screening feature to
minimize false positives (Gene Expression: S12;
Correlations Center S14) (Figure 3) and
. Implementation of a ‘workbook’ feature to help
users pare-down and gather candidate genes with an
option to generate an output of gene IDs for quick
copy–paste into other bioinformatics resources
(Figure 3).
MPD has been exploring and evaluating methods for
genome-wide association studies (GWAS) that may be
developed into general tools for MPD users. One
approach that has received a lot of attention is the ‘ef-
ﬁcient mixed-model method’ (EMMA), which corrects
for inbred strain population structure thereby signiﬁ-
cantly reducing the number of false positive associations
(30). GWAS results for selected MPD measurements
(e.g. testing at least 20 strains) are available in collab-
oration with the UCLA Computer Science and
Bioinformatics group (ZarLab) using EMMA and the
Mouse HapMap for 94 inbred strains at 132K locations
(2). Wild-derived strains are automatically excluded
from these analyses (see more details in Figure 2). For
ineligible MPD measurements (<20 strains), MPD
provides an option to produce input-ready ﬁles speciﬁc-
ally formatted for a real-time run on the UCLA EMMA
Server (mouse.cs.ucla.edu/emmaserver). Users can
choose to include wild-derived strains and are able to
further manipulate the input ﬁle, e.g. to delete speciﬁc
strains, and to select other SNP data sets for
interrogation.
Figure 1. Phenotype data: new layout, viewing options and tools. An MPD summary plot is shown from an aging study measuring IGF-1 levels in
males and females of 33 inbred strains at 6months of age [Yuan1 (28); see also accompanying paper (29)]. From this plot, users have several choices
for viewing (see plot options), and there are one-click options for deploying relevant tools speciﬁc for this measurement (boxed selections just above
the plot), which include ﬁnding other phenotype measurements that correlate signiﬁcantly, ﬁnding genes with correlated expression patterns and
performing EMMA-corrected genome-wide association analysis (GWAS). For most MPD measurements with at least 20 inbred strains tested, the
GWAS option is a direct link to pre-computed results hosted on the UCLA EMMA website (see text). About the plot: strain means are shown (±1
SEM); dotted horizontal lines indicate 1 SD for the overall strain mean (red=female; blue=male). All words in blue are links to tools, other views
or additional information. For a continuation of this example, see Figure 2 (GWAS) and Figure 3 (gene expression).
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MPD has also implemented the following since our last
NAR update:
. Correlations Center: centralizes, organizes and
explains all MPD correlation operations on a single
webpage; and provides convenient links to relevant
tools (Correlations Center: S14).
. Private Analysis Portal: users enter their own experi-
mental data and run real-time regression analysis
across the entire MPD to identify statistically signiﬁ-
cant correlations to existing phenotype and gene ex-
pression data (Private Analysis Portal: S15) and
. Tool to generate ratio or difference vectors for
user-selected MPD measurements: users can view
plots and identify independent MPD measurements
that are highly correlated to the de novo generated
vector (MPD Toolbox Demo: S13; Correlations
Center: S14).
Additional supplementary data
Individual animal data, summary statistics and other
metadata are available for downloading in bulk or in
customized data sets speciﬁed by the user (Download
Center: S16; SNP Downloads: S11). For convenience,
we are providing Supplemental Material for general
content and information (MPD Content and Quick
Facts: S17) and a user’s manual (MPD User Manual
and FAQ: S18).
HIGH-LEVEL OVERVIEW OF IMPLEMENTATION
The speciﬁcs of our implementation have not changed sig-
niﬁcantly since our previous update (11). MPD runs on a
SUSE Linux/Apache 2 system using open source
database, HTML generation and graphics generation
software, with custom-written C modules used in
performance-critical areas. Phenotype data sets are typic-
ally submitted by data contributors as Excel spreadsheets.
Genotype and gene expression data sets are usually down-
loaded by us from open public resources. Ad hoc process-
ing methods are used to integrate these data into our
standardized framework. In conjunction with data con-
tributors, MPD staff creates supporting documentation
in HTML. We add content and perform testing and QA
on an internal development node; then this instance is
copied over for public release. MPD follows an agile de-
velopment philosophy with rapid prototyping and
frequent updates; version numbering is not used. For
Figure 2. New GWAS tools. Continuing with the IGF-1 example [Yuan1 (28)], we performed a genome-wide association analysis by clicking on the
‘GWAS’ option above the plot shown in Figure 1 (the relevant part of this panel is shown here for convenience). We found signiﬁcant
EMMA-corrected peaks for females on chromosomes 2, 10, 13, 14, 15, 17 and 18 (lower panel; green stars were manually overlaid on this plot
to ensure visibility of peaks). Interestingly Leduc et al. (29) (the data submitter’s publication for Yuan1) found three of the same in silico QTLs using
another method, haplotype association mapping (HAM), which employed the Hidden Markov Model and a set of SNPs at 70K locations (includes
imputed calls). We chose to concentrate on the most signiﬁcant peak identiﬁed by these methods on Chr 10 in the vicinity of the Igf1 gene. Using
other supporting data sets and bioinformatics tools, Leduc et al. narrowed their results from over 45 genes annotated in the QTL interval to 21
candidate genes. We wondered if we might narrow these results even further by using another new MPD tool for ﬁnding signiﬁcant gene expression
correlations (see Figure 3). The new GWAS tool is provided in collaboration with the UCLA Computer Science and Bioinformatics group (ZarLab)
(30). MPD is not responsible for the UCLA website or EMMA Server (mouse.cs.ucla.edu/emmaserver).
Nucleic Acids Research, 2012,Vol.40, Database issue D891Figure 3. New gene expression interface. Continuing with the IGF-1 example [Yuan1 (28)] from Figures 1 and 2, we interrogated the Chr 10 QTL
interval (84.5–90.0Mbp) identiﬁed by both association mapping methods (HAM and EMMA) using the new MPD gene expression interface. Users
can simply click on the correlated probes/genes option above the plot shown in Figure 1 (the relevant part of this panel is shown in the upper-left
panel for convenience), or users may choose to begin in the Correlations Center (S14). Of those 21 candidate genes identiﬁed by Leduc et al.( 29) (see
Figure 2), we went on to conﬁrm that 6 of those genes had compelling expression proﬁles consistent with IGF-1 levels (P<0.05). Three of these
genes are listed in the middle-left panel (see Note 1 for more information about this panel). As indicated, three probesets from two gene expression
projects [GX-Su1 (31,32), GX-Tabakoff1 (33)] were identiﬁed using various ﬁltering and sorting options that are available with this tool. Users can
adjust stringency to broaden or narrow results by selecting P-value cutoff and setting the data point variance (DPV) quality ﬁlter where stricter
settings will omit probesets that have larger standard errors relative to the range of strain means. Users may further ﬁlter results by minimum
number of strains, sex, speciﬁc data set and chromosome. Results can be sorted by P-value, correlation coefﬁcient, location order, MPD project or
MPD category. A phenotype-gene expression scatterplot is available through the ‘Plot’ link. IGF-1 versus Nr1h4 for males is shown in the lower-left
panel. By clicking on gene name, we accessed the gene directory page (lower-right panel, and see Note 2 below), to deploy the 550K SNP panel
[CGD2 (3,6)] speciﬁcally for the gene of interest to compare the segregation of phenotype with polymorphisms. Using MPD SNP tools, we conﬁrmed
that three of the six genes have polymorphic intronic or UTR regions, consistent with the notion that these genes are differentially regulated. The
corresponding SNP results for Nr1h4 are shown (middle-right panel) where strains are grouped according to ‘hi’ (left) or ‘lo’ (right) IGF-1 levels.
These strains fall into two major haplotypes (wild-derived strains fall into a third haplotype, not shown). For ease of comparison, an optional view of
the male IGF-1 data is shown in the upper-right panel [color-guides from the SNP results to plot: blue=high IGF-1 levels, yellow=low IGF-1
levels (see also, strain distribution in Figure 1)]. All words in blue are links to tools, other views or additional information. While we demonstrate
that MPD can help identify (or further verify) candidate genes exhibiting differential expression, we also note that caution should be used in making
claims of causality based solely on microarray data, SNPs and functional relevance of positional candidates. All MPD phenotype-gene expression
pair-wise correlations are available for bulk download (Download Center: S16). Note 1: The ‘collect gene’ option in the middle of the gene expression
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(continued)more documentation, see MPD ‘BioDBcore Statement’
(S19). Information for developers is also available (For
Developers: S20).
FUTURE MPD DIRECTIONS AND AN INVITATION
TO INVESTIGATORS
MPD will continue implementing useful linkages to other
databases and populating the database with phenotype,
genotype and gene expression data. We continue to
reﬁne MPD data classiﬁcations with relevant ontologies,
optimizing search and navigation functionality as well as
facilitating data integration within MPD and across data-
bases. We are in the process of loading Sanger SNPs,
indels and structural variants derived from whole-genome
sequencing of 17 inbred mouse strains (7,8), and we will
take advantage of the availability of the RNA-seq data
being released by Sanger on this set of strains. RNA-seq
data will complement existing MPD data and will enable
queries to determine expression levels of different alleles of
a gene and to detect post-transcriptional mutations or
other genetic alterations.
Many phenotypic domains are currently represented in
MPD; however, the acquisition of new data is open-ended
with the goal of collecting data on a broader scope (and in
some cases to a deeper level for more granular phenotypes
or endophenotypes) as well as collecting data generated
from new, more sophisticated phenotyping technologies.
Although we have added a signiﬁcant number of pheno-
types since our last update (Table 2), we will continue
working toward accessioning more data for inbred
strains and other strain types as well as for new panels
such as the Collaborative Cross (34–36). We would like
to take this opportunity to make an appeal for clinically
relevant data in toxicology and speciﬁc disease areas:
cancer, digestive diseases, kidney disease, neurological dis-
orders, drug addiction and infectious diseases. To expand
the scope and maximize the utility of MPD, members of
the global scientiﬁc community are invited to contribute
their strain survey data or join us in a coordinated effort
to seek funding that will support these studies. This spirit
of collaboration has shaped and will continue to guide the
future growth and development of MPD. Researchers
interested in contributing data or in collaborating
on new phenotyping projects should contact us at
phenome@jax.org. Data submission guidelines are access-
ible through the MPD homepage (Contributing
Data: S21).
CITING MPD AND USER SUPPORT
For general citation of MPD, this NAR article may be
used. In addition, the following citation format is
preferred when referring to MPD projects or using MPD
data sets.
Investigator(s) name (year project posted) Project title. MPD
project symbol (e.g. Smith1) and/or accession number
(MPD:XXX). Mouse Phenome Database Website, The
Jackson Laboratory, Bar Harbor, ME, USA. (URL: http://
phenome.jax.org), date of download or access.
For more information visit our website and search on
‘citing’.
MPD provides user support through online documen-
tation (S17, S18) and via email (phenome@jax.org). We
welcome user input and suggestions, which can be
submitted anonymously through our Suggestion Box
links at the bottom of most MPD webpages.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1.
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Figure 3. Continued
results (middle-left panel) is one place where users can take advantage of our new ‘workbook’ feature for paring down and gathering candidate genes.
Lists are provided a new window, and checkboxes are supplied to exclude (or include) genes in an updated list. At any time, users may opt to
generate a separate clean list of gene symbols or various accession ID options to copy/paste into batch query forms of other bioinformatics resources.
Note 2: The gene directory box shown in the bottom–right panel is a hub for information and linkouts to other resources (additional features are
added as needed). We provide one-click deployment to SNP tools, ﬁnding MPD phenotype measurements that correlate, and information about
available gene expression probesets, including tools to compare probesets between gene expression projects and to compare female and male for a
single probeset within a project. Users will arrive at a gene directory page from any gene link on the MPD website, from gene searches and from
general searches that turn up genes. For Developers wanting to link to our gene directory page, use this URL template: http://phenome.jax.
org/db/qp?rtn=markers/details&reqsym=Abcd1, where Abcd1 is gene symbol (For Developers: S22).
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